77 related articles for article (PubMed ID: 8940637)
1. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors.
Zepeda M; Wilson JM
Gene Ther; 1996 Nov; 3(11):973-9. PubMed ID: 8940637
[TBL] [Abstract][Full Text] [Related]
2. Cationic liposome conjugation to recombinant adenoviral vector reduces viral antigenicity.
Natsume A; Mizuno M; Ryuke Y; Yoshida J
Jpn J Cancer Res; 2000 Apr; 91(4):363-7. PubMed ID: 10804282
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer into rat brain using adenoviral vectors.
Puntel M; Kroeger KM; Sanderson NS; Thomas CE; Castro MG; Lowenstein PR
Curr Protoc Neurosci; 2010 Jan; Chapter 4():Unit 4.24. PubMed ID: 20066657
[TBL] [Abstract][Full Text] [Related]
4. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.
Batliwalla FM; Bateman BA; Serrano D; Murray D; Macphail S; Maino VC; Ansel JC; Gregersen PK; Armstrong CA
Mol Med; 1998 Dec; 4(12):783-94. PubMed ID: 9990864
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of 8-Cl-cAMP action.
Juranić Z; Radulović S; Joksimović J; Juranić I
J Exp Clin Cancer Res; 1998 Sep; 17(3):269-75. PubMed ID: 9894761
[TBL] [Abstract][Full Text] [Related]
6. High-dose adjuvant interferon therapy for melanoma.
Licata AG
Dermatol Nurs; 1998 Oct; 10(5):334-6. PubMed ID: 9873271
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation.
Yokota T; Nishio H; Kubota Y; Mizoguchi M
Pigment Cell Res; 1998 Dec; 11(6):355-61. PubMed ID: 9870547
[TBL] [Abstract][Full Text] [Related]
8. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology.
Simons JW; Mikhak B
Semin Oncol; 1998 Dec; 25(6):661-76. PubMed ID: 9865681
[TBL] [Abstract][Full Text] [Related]
9. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma.
Pica F; Fraschetti M; Matteucci C; Tuthill C; Rasi G
Anticancer Res; 1998; 18(5A):3571-8. PubMed ID: 9858941
[TBL] [Abstract][Full Text] [Related]
10. Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-inactivating protein luffin.
Poma A; Miranda M; Spanò L
Melanoma Res; 1998 Oct; 8(5):465-7. PubMed ID: 9835461
[TBL] [Abstract][Full Text] [Related]
11. Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target.
Kanter-Lewensohn L; Dricu A; Wang M; Wejde J; Kiessling R; Larsson O
Melanoma Res; 1998 Oct; 8(5):389-97. PubMed ID: 9835451
[TBL] [Abstract][Full Text] [Related]
12. Expression of adhesion molecule CD44 in metastatic brain tumors.
Harabin-Słowińska M; Słowiński J; Konecki J; Mrówka R
Folia Neuropathol; 1998; 36(3):179-84. PubMed ID: 9833394
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
[TBL] [Abstract][Full Text] [Related]
14. The PTEN tumour suppressor gene and malignant melanoma.
Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
[TBL] [Abstract][Full Text] [Related]
15. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
[TBL] [Abstract][Full Text] [Related]
16. Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNS.
Schwarz MJ; Müller N; Körschenhausen D; Kirsch KH; Penning R; Ackenheil M; Johnson JP; Hampel H
Neuroimmunomodulation; 1998; 5(5):270-6. PubMed ID: 9730695
[TBL] [Abstract][Full Text] [Related]
17. PKC-dependent modulation of IkB alpha-NFkB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells.
La Porta CA; Comolli R
Anticancer Res; 1998; 18(4A):2591-7. PubMed ID: 9703914
[TBL] [Abstract][Full Text] [Related]
18. Evaluation on serum 2'-5'oligoadenylate synthetase (2'-5'oligoAS) and beta 2 microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha 2A.
Martinetti A; Seregni E; Belli F; Mazzocchi A; Agresti R; Cascinelli N; Greco M; Bombardieri E
Anticancer Res; 1998; 18(3B):2027-30. PubMed ID: 9677461
[TBL] [Abstract][Full Text] [Related]
19. Preclinical studies with prothymosin alpha1 on mononuclear cells from tumor patients.
Eckert K; Grünberg E; Garbin F; Maurer HR
Int J Immunopharmacol; 1997; 19(9-10):493-500. PubMed ID: 9637344
[TBL] [Abstract][Full Text] [Related]
20. The use of recombinant adeno-associated viral vectors for the transduction of epithelial tumor cells.
Hoerer M; Bogedain C; Scheer U; Heberger C; Steyrer S; Burger A; Maass G
Int J Immunopharmacol; 1997; 19(9-10):473-9. PubMed ID: 9637341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
